Multiple Myeloma Posts Page 2 on Medivizor
Navigation Menu

Multiple Myeloma Posts on Medivizor

Evaluating carfilzomib plus dexamethasone for relapsed or refractory multiple myeloma

Posted by on Mar 10, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the impact of carfilzomib (Kyprolis) and dexamethasone (Decadron) on quality of life for patients with relapsed or refractory (does not respond to treatment) multiple myeloma (MM). This study concluded that patients treated with this combination had a higher quality of life. Some background MM is a...

Read More

Bortezomib plus lenalidomide for patients with multiple myeloma a after stem cell transplant

Posted by on Mar 5, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of bortezomib (Velcade) and lenalidomide (Revlimid) for patients with multiple myeloma after stem cell transplantation. This study found this combination is effective for these patients, with few side effects. Some background Multiple myeloma (MM) is a type of cancer...

Read More

Bortezomib plus lenalidomide for patients with multiple myeloma a after stem cell transplant

Posted by on Mar 5, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of bortezomib (Velcade) and lenalidomide (Revlimid) for patients with multiple myeloma after stem cell transplantation. This study found this combination is effective for these patients, with few side effects. Some background Multiple myeloma (MM) is a type of cancer...

Read More

Lenalidomide maintenance therapy after a stem cell transplant for multiple myeloma

Posted by on Feb 28, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the outcomes of maintenance therapy with lenalidomide (Revlimid) after autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM). This study concluded that longer lenalidomide maintenance leads to improved survival outcomes in these patients. Some background Multiple myeloma is a type of...

Read More

Oncolytic Virus Treatments

Oncolytic Virus Treatments

Posted by on Feb 10, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 0 comments

In 1904, a physician wrote about a patient with leukemia who went into remission when he got the flu. Though the patient was not cured, it was a ray of hope at a time when there were no treatments for leukemia. Other cases were reported throughout the years of people with Burkitt’s Lymphoma and Hodgkin’s Lymphoma going into remission when they...

Read More

Is stem cell transplant more effective than other treatments for multiple myeloma?

Posted by on Feb 5, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study compared the effects of stem cell transplant to other newer treatments for recently diagnosed multiple myeloma (MM). The main finding was patients who received stem cell transplant had better outcomes than those who did not. Some background Stem cell transplant involves the transfer of cells to a patient. This is an effective...

Read More

Minimal residual disease and its association with transplant success in Multiple Myeloma.

Posted by on Jan 27, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study monitored the development of minimal residual disease (MRD) after transplant for multiple myeloma (MM). The main finding was that different patterns of MRD development are associated with varying success after stem cell transplant for MM. Some background There are many treatments for MM. Patients are often cured fully by...

Read More

ASCO’s National Cancer Opinion Survey Results

ASCO’s National Cancer Opinion Survey Results

Posted by on Jan 24, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

During July and early August of  2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...

Read More

How effective and safe is pomalidomide in relapsed/refractory multiple myeloma?

Posted by on Jan 17, 2019 in Multiple Myeloma | 0 comments

In a nutshell This article investigated the safety and effectiveness of pomalidomide (Pomalyst) for the treatment of relapsed or refractory (does not respond to treatment) multiple myeloma (RRMM) in a real-life setting. The authors concluded that this treatment is safe and effective in these patients.  Some background Multiple myeloma...

Read More

Kidney problems in Multiple Myeloma: do they affect the success of stem cell transplant?

Posted by on Jan 5, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the effect of kidney problems on the success of stem-cell transplant for Multiple Myeloma (MM). The main finding was that the stage of the kidney problems did not impact the effects of stem-cell transplant. Some background Stem-cell transplant involves the transfer of cells to a patient. It is commonly used in the...

Read More